Oncology Institute (TOI) Interest & Investment Income (2020 - 2023)

Oncology Institute has reported Interest & Investment Income for 3 years, with the latest figure at $940000.0 in Q3 2023.

• For the quarter ending Q3 2023, Interest & Investment Income changed N/A year-over-year to $940000.0; the trailing twelve-month figure through Sep 2023 stood at $3.2 million (up 54763.75% YoY), and the FY2020 full-year result was $254149.0, changed N/A from the prior year.
• Interest & Investment Income for Q3 2023 stood at $940000.0, down from $1.0 million in the prior quarter.
• The five-year high for Interest & Investment Income was $1.2 million in Q1 2023, with the low at $5798.0 in Q3 2021.
• Historically, Interest & Investment Income has averaged $383437.7 across 3 years, with a median of $73393.0 in 2020.
• The largest YoY upside for Interest & Investment Income was 91.48% in 2021 against a maximum downside of 92.1% in 2021.
• Oncology Institute's Interest & Investment Income stood at $59248.0 in 2020, then plunged by 90.21% to $5798.0 in 2021, then soared by 16112.49% to $940000.0 in 2023.
• The last three Interest & Investment Income figures came in at $940000.0 (Q3 2023), $1.0 million (Q2 2023), and $1.2 million (Q1 2023), per Business Quant data.